Erkut Bahceci, MD, CMO of BlueSphere Bio, discusses how CMOs can use adaptive approaches, real world data and ex-US trials to accelerate drug development.
Lead Editorial

Erkut Bahceci, MD, CMO of BlueSphere Bio, discusses how CMOs can use adaptive approaches, real world data and ex-US trials to accelerate drug development.